Marker Therapeutics, Inc. (MRKR)

NASDAQ

$1.07

$+0.18

(+20.11%)

Regular Market

Marker Therapeutics, Inc. (MRKR) Live Price Chart

Last updated: ⁦2026-10-16 17:51:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Marker Therapeutics, Inc. (MRKR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.07, with a market capitalization of $14.84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.84 to $2.46. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$14.84M
Open	$1.02
Day's High	$102.50
Day's Low	$0.67
Previous Close	$0.92
Volume	1.01M
Average Volume	71.85K
P/E Ratio	--
52-Week High	$2.46
52-Week Low	$0.84
Dividend Yield	--
Earnings Date	--

Marker Therapeutics, Inc. (MRKR) Stock Price Today

Marker Therapeutics, Inc. (MRKR) is currently trading at $1.07 as of 2026-10-16 17:49:00, up 16.74% ($0.15) from the previous close of $0.92

During today's regular trading session, MRKR has traded between $0.67 and $102.50, with a trading volume of 1.01M shares. The current price is near the lower end of today's range.

Marker Therapeutics, Inc. (MRKR) 7-Day Stock Price Change

Over the past seven days, Marker Therapeutics, Inc. (MRKR) moved from $1.04 to $1.07, representing a gain of 3.27% ($0.03).

The stock traded between $0.88 and $1.19 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 100.09 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

MRKR 52-Week Price Position

Position in Range: 14.4%

52W Low$0.84

52W High$2.46

MRKR is currently trading at $1.07, placing it 14.4% of the way from its 52-week low of $0.84 to its 52-week high of $2.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Marker Therapeutics, Inc. (MRKR)?

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Marker Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.markertherapeutics.com

How to Buy Marker Therapeutics, Inc. (MRKR) Stock on MEXC

Eligible investors can buy real shares of Marker Therapeutics, Inc. (MRKR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MRKR and Place Your Order

Open the RealStocks trading page and search for MRKR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Marker Therapeutics, Inc. (MRKR) stock price today?

Marker Therapeutics, Inc. (MRKR) is currently trading at $ 1.07, up 16.74% ($0.15) from the previous close of $ 0.92. Intraday prices update in real time during regular trading hours.

2.Is MRKR stock going up or down today?

As of 2026-10-16 17:49:00, MRKR is trading at $ 1.07, up 16.74% ($0.15) from its previous close of $ 0.92. The stock has traded between $ 0.67 and $ 102.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is MRKR pre-market price?

As of 2026-10-16 17:49:00, MRKR is trading at $ 1.01 in pre-market trading, up 9.89% ($0.09) from the previous close of $ 0.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MRKR after-hours price?

As of 2026-10-16 17:49:00, MRKR is trading at $ 0.94 in after-hours trading, up 2.17% ($0.02) from the regular-session close of $ 0.92. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MRKR stock trading now?

MRKR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MRKR sit relative to its 52-week high and low?

Over the past 52 weeks, MRKR has traded between a low of $ 0.84 and a high of $ 2.46. At $ 1.07, the stock is positioned 14.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Marker Therapeutics, Inc. in?

Marker Therapeutics, Inc. (MRKR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Marker Therapeutics, Inc.'s market capitalization and where is it listed?

Marker Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 14.84M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MRKR valued in terms of P/E ratio and EPS?

MRKR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.52. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Marker Therapeutics, Inc. pay a dividend?

Marker Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.